Ralpancizumab (anti-PCSK9) is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182733-SCI_cd5e91e7cdd54977f3bbdc5483428646.pdf
- UPC:
- 51131749
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182733-5mg
- CAS:
- 1407495-04-8
- Product Size:
- 5mg